Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omicron-Delta COVID-19 Vaccine Booster Trial
NCT05616754Phase 3Unknown
- Sponsor
- Zhifei Biological
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine in coronavirus disease 2019 (COVID-19), sponsored by Zhifei Biological. Status: unknown.
02
Drugs
Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05616754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05616754.